{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T22:19:32Z","timestamp":1715552372864},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"suppl_2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1212\/wnl.57.suppl_2.s12","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:57:25Z","timestamp":1336917445000},"source":"Crossref","is-referenced-by-count":6,"title":["From bench to bedside"],"prefix":"10.1212","volume":"57","author":[{"given":"Dan J.","family":"Fintel","sequence":"first","affiliation":[{"name":"From the Coronary Care Unit, Northwestern University School of Medicine, Chicago, Illinois."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","first-page":"253","volume":"28","year":"1918","unstructured":"Glanzmann E. Hereditare haemorrhagische Thrombasthenie: ein Beitrag zur Pathologie der Blutplattchen. Jahrbuch Kinderheilk . 1918; 28: 253\u2013260.","journal-title":"Jahrbuch Kinderheilk"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1974.tb06660.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112907"},{"key":"e_1_3_2_5_2","first-page":"38","volume":"82","year":"1990","unstructured":"Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation . 1990; 82 (suppl II): 38\u201346.","journal-title":"Circulation"},{"key":"e_1_3_2_6_2","first-page":"17","volume":"79","year":"1997","unstructured":"Shah PK. New insights into the pathogenesis and prevention of acute coronary syndromes. Am J Cardiol . 1997; 79 (suppl 12B): 17\u201323.","journal-title":"Am J Cardiol"},{"key":"e_1_3_2_7_2","unstructured":"Coller   BS.   Platelets in cardiovascular thrombosis and thrombolysis.  In:  Fozzard  HA Haber  E Jennings  RB eds.  The Heart and Cardiovascular System: Scientific Foundations.   New York:   Raven Press 1992:  219\u2013273."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506083322306"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90233-9"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.23.8057"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.22.10729"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1996.tb00962.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110973"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00299-3"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)92826-7"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.3.528"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.11.1085"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.17.1680"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.4.1757"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80345-2"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00500-5"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","unstructured":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 1994;330:956\u2013961.","DOI":"10.1056\/NEJM199404073301402"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00110-1"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550060055036"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","unstructured":"Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study [see Comments] [published erratum appears in Lancet 1997;350:744]. Lancet 1997;349:1429\u20131435.","DOI":"10.1016\/S0140-6736(96)10452-9"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905273402103"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","unstructured":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators [see Comments] [published erratum appears in N Engl J Med 1998;339:415]. N Engl J Med 1998;338:1488\u20131497.","DOI":"10.1056\/NEJM199805213382102"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","unstructured":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb\/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy [see Comments]. N Engl J Med 1998;339:436\u2013443.","DOI":"10.1056\/NEJM199808133390704"},{"key":"e_1_3_2_29_2","first-page":"I-359.","volume":"98","year":"1998","unstructured":"Harrington RA, Lincoff AM, Berdan LG, et al. Maintenance of clinical benefit at six-months in patients treated with platelet glycoprotein IIb\/IIIa inhibitor eptifibatide versus placebo during an acute ischemic coronary event [Abstract]. Circulation . 1998; 98 (suppl 17): I-359.","journal-title":"Circulation"},{"key":"e_1_3_2_30_2","first-page":"I-560","volume":"98","year":"1998","unstructured":"Bhatt DL, Marso SP, Houghtaling P, Labinaz M, Lauer MA. Does earlier administration of eptifibatide reduce death and MI in patients with acute coronary syndromes? [Abstract]. Circulation . 1998; 98 (suppl 17): I-560\u2013I-561.","journal-title":"Circulation"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00342-7"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.1.14"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/full\/10.1212\/WNL.57.suppl_2.S12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:25:05Z","timestamp":1711643105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.57.suppl_2.S12"}},"subtitle":["GP IIb\u2013IIIa inhibitors"],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":31,"journal-issue":{"issue":"suppl_2","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1212\/WNL.57.suppl_2.S12"],"URL":"https:\/\/doi.org\/10.1212\/wnl.57.suppl_2.s12","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}